In this discussion, Michelle Longmire, Co-founder and CEO of Medable, shares her insights on how AI is revolutionizing clinical trials. She explains how AI enhances patient experiences and streamlines processes for sponsors. Michelle dives into the importance of real-time data analysis and smarter recruitment strategies in drug development. She also addresses the challenges of integrating AI within existing frameworks and the need for organizations to balance speed with regulatory compliance. This conversation offers a forward-thinking perspective on the future of clinical research.